期刊
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM
卷 4, 期 3, 页码 164-172出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/ncpendmet0729
关键词
diabetes; genetics; metabolism; mouse models; targeted mutagenesis
资金
- NIDDK NIH HHS [R37 DK058282, R01 DK057539-07, R01 DK058282-07, P30 DK063608, R01 DK064819, P30 DK063608-07, R01 DK057539, R01 DK058282] Funding Source: Medline
- NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058282, P30DK063608, R37DK058282, R01DK057539, R01DK064819] Funding Source: NIH RePORTER
A wide range of genetically engineered murine models of type 2 diabetes have been created to try to understand the site of the primary defect in insulin action, and the relationship between insulin resistance and impaired P-cell function in diabetes. Genetic disruption of various aspects known to be important in diabetes has examined specific facets, including glucose sensing, transcription factors for the insulin gene, the insulin gene itself, insulin and insulin-like growth factor receptors, downstream signaling components and some mutations that increase insulin sensitivity. This article focuses on models that have given insight into insulin resistance and impaired insulin production, especially models that examine molecules involved in the signaling pathway downstream of insulin binding its receptor. These models recapitulate many features of human type 2 diabetes and, although they have emphasized the complexity of this disease, they offer numerous opportunities to characterize particular aspects and eventually fit them together to help delineate the human disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据